Gene Expression Profiling of Human Monocyte-derived Dendritic Cells – Searching for Molecular Regulators of Tolerogenicity
Open Access
- 19 October 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 528
Abstract
The ability of dendritic cells (DCs) to initiate and modulate antigen-specific immune responses has made them attractive targets for immunotherapy. Since DC research in humans is limited by the scarcity of DC populations in the blood circulation, most of our knowledge about DC biology and function has been obtained in vitro from monocyte-derived DCs (moDCs), which can be readily generated in sufficient numbers and are able to differentiate into distinct functional subsets depending on the nature of stimulus. In particular, moDCs with tolerogenic properties (tolDCs) possess great therapeutic potential for the treatment of autoimmune diseases. Several protocols have been developed to generate tolDCs in vitro, able to reinstruct auto-reactive T cells and to promote regulatory cells. While ligands and soluble mediators, by which DCs shape immune responses, have been vastly studied, the intracellular pathways and transcriptional regulators that govern tolDC differentiation and function are poorly understood. Whole-genome microarrays and proteomics provide useful strategies to dissect the complex molecular processes that promote tolerogenicity. Only few attempts have been made to understand tolDC biology through a global view on ‘omics’ profiles. So far, the identification of a common regulator of tolerogenicity has been hampered by the fact that each protocol, used for tolDC generation, targets distinct signaling pathways. Here we review the progress in understanding the transcriptional regulation of moDC differentiation, with a special focus on tolDCs, and highlight candidate molecules that might be associated with DC tolerogenicity.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (1140553, 3150453 (KS))
- Millennium Institute on Immunology and Immunotherapy (P09-016-F)
- Fundación Ciencia Translacional from Chile
- Comisión Nacional de Investigación Científica y Tecnológica (21130701 (PGG))
This publication has 86 references indexed in Scilit:
- A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokinesJournal of Translational Medicine, 2013
- Re(de)fining the dendritic cell lineageNature Immunology, 2012
- Monocyte-derived DC maturation strategies and related pathways: a transcriptional viewCancer Immunology, Immunotherapy, 2011
- Curcumin induces maturation-arrested dendritic cells that expand regulatory T cellsin vitroandin vivoClinical and Experimental Immunology, 2010
- Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activationImmunology, 2010
- Generation of Stable Th1/CTL-, Th2-, and Th17-Inducing Human Dendritic Cells2009
- Evaluation of 3 Clinical Dendritic Cell Maturation Protocols Containing Lipopolysaccharide and Interferon-γJournal of Immunotherapy, 2009
- Dexamethasone transforms lipopolysaccharide‐stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin‐10 production in T cellsImmunology, 2008
- Monocyte derived dendritic cells generated by IFN-α acquire mature dendritic and natural killer cell properties as shown by gene expression analysisJournal of Translational Medicine, 2007